IMMUNE-MEDIATED BASIS FOR A PHASE 2A CLINICAL STUDY COMPARING RILZABRUTINIB VS GLUCOCORTICOIDS IN RITUXIMAB-REFRACTORY PATIENTS WITH IGG4-RELATED DISEASE Long, L., Baker, M., Carruthers, M., Meysami, A., Spiera, R., Reddy, M., Kavanagh, M., Francesco, M., Langrish, C., Neale, A., Arora, P., Stone, J. H. BMJ PUBLISHING GROUP. 2021: 1406

View details for DOI 10.1136/annrheumdis-2021-eular.407

View details for Web of Science ID 000692625300748